Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical research study is to find the recommended dose of monzosertib in patients with relapsed/refractory AML and high-risk MDS. The safety and effects of monzosertib will also be studied.
Who Is on the Research Team?
Abhishek Maiti, MBBS
Principal Investigator
UT MD Anderson Cancer Center
Are You a Good Fit for This Trial?
What Are the Treatments Tested in This Trial?
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Participants may initiate treatment in the inpatient environment, at the discretion of the treating physician.
Participants may initiate treatment in the inpatient environment, at the discretion of the treating physician.
Participants may initiate treatment in the inpatient environment, at the discretion of the treating physician.
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Carna Biosciences, Inc.
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.